SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
Morgan Stanley Global Healthcare Conference | ||
Date: Tuesday, September 14, 2010 | ||
Time: 10:55am Eastern Time (7:55am Pacific Time) | ||
Place: Grand Hyatt Hotel in New York City | ||
Speaker: Ted Schroeder, President & CEO | ||
Stifel Nicolaus Healthcare Conference 2010 | ||
Date: Thursday, September 16, 2010 | ||
Time: 8:00am Eastern Time (5:00am Pacific Time) | ||
Place: Four Seasons Hotel in Boston | ||
Speaker: Ted Schroeder, President & CEO | ||
UBS Global Life Sciences Conference | ||
Date: Wednesday, September 22, 2010 | ||
Time: 10:00am Eastern Time (7:00am Pacific Time) | ||
Place: Grand Hyatt Hotel in New York City | ||
Speaker: William R. LaRue, SVP & CFO | ||
JMP Securities Healthcare Conference | ||
Date: Monday, September 27, 2010 | ||
Time: 10:00am Eastern Time (7:00am Pacific Time) | ||
Place: The New York Palace Hotel in New York City | ||
Speaker: Ted Schroeder, President & CEO | ||
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 | |
SOURCE Cadence Pharmaceuticals, Inc.
